Compare AER & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AER | BNTX |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | Ireland | Germany |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0B | 24.8B |
| IPO Year | 2006 | 2019 |
| Metric | AER | BNTX |
|---|---|---|
| Price | $144.84 | $95.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $146.29 | $137.40 |
| AVG Volume (30 Days) | 1.5M | ★ 1.6M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 63.90 | N/A |
| EPS | ★ 20.89 | N/A |
| Revenue | ★ $8,344,637,000.00 | $3,698,814,972.00 |
| Revenue This Year | $4.58 | $2.03 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.95 | ★ N/A |
| Revenue Growth | ★ 6.67 | 3.70 |
| 52 Week Low | $85.57 | $81.20 |
| 52 Week High | $146.67 | $129.27 |
| Indicator | AER | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 70.93 | 45.60 |
| Support Level | $140.35 | $91.32 |
| Resistance Level | $146.67 | $93.76 |
| Average True Range (ATR) | 2.11 | 2.09 |
| MACD | 0.27 | 0.18 |
| Stochastic Oscillator | 83.43 | 46.39 |
AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.